These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32981311)

  • 1. Collagen Hydrolysate Corrects Anemia in Chronic Kidney Disease via Anti-Inflammatory Renoprotection and HIF-2α-Dependent Erythropoietin and Hepcidin Regulation.
    Zhu S; Wu L; Zhang J; Miao Y; Zhao Y; Zeng M; Li D; Wu H
    J Agric Food Chem; 2020 Oct; 68(42):11726-11734. PubMed ID: 32981311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepcidin in chronic kidney disease anemia.
    Santos-Silva A; Ribeiro S; Reis F; Belo L
    Vitam Horm; 2019; 110():243-264. PubMed ID: 30798815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible mechanisms by which silkworm faeces extract ameliorates adenine-induced renal anaemia in rats.
    Mei H; Wu N; Huang X; Cui Z; Xu J; Yang X; Zeng F; Wang K
    J Ethnopharmacol; 2021 Feb; 266():113448. PubMed ID: 33022342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepcidin as a therapeutic target for anemia and inflammation associated with chronic kidney disease.
    Malyszko J; Malyszko JS; Matuszkiewicz-Rowinska J
    Expert Opin Ther Targets; 2019 May; 23(5):407-421. PubMed ID: 30907175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia.
    Landau D; London L; Bandach I; Segev Y
    PLoS One; 2018; 13(5):e0196684. PubMed ID: 29738538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin and a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHDi) lowers FGF23 in a model of chronic kidney disease (CKD).
    Noonan ML; Clinkenbeard EL; Ni P; Swallow EA; Tippen SP; Agoro R; Allen MR; White KE
    Physiol Rep; 2020 Jun; 8(11):e14434. PubMed ID: 32476270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-inducible factor prolyl hydroxylase inhibitors: a paradigm shift for treatment of anemia in chronic kidney disease?
    Souza E; Cho KH; Harris ST; Flindt NR; Watt RK; Pai AB
    Expert Opin Investig Drugs; 2020 Aug; 29(8):831-844. PubMed ID: 32476498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Renal anemia and hypoxia-inducible factor prolyl hydroxylase inhibitor].
    Maruno S; Tanaka T; Nangaku M
    Rinsho Ketsueki; 2021; 62(5):371-377. PubMed ID: 34108317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of chronic kidney disease-associated anemia by vadadustat in mice is not dependent on erythroferrone.
    Hanudel MR; Wong S; Jung G; Qiao B; Gabayan V; Zuk A; Ganz T
    Kidney Int; 2021 Jul; 100(1):79-89. PubMed ID: 33811979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIF stabilizers in the management of renal anemia: from bench to bedside to pediatrics.
    Kular D; Macdougall IC
    Pediatr Nephrol; 2019 Mar; 34(3):365-378. PubMed ID: 29569190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugs activating hypoxia-inducible factors correct erythropoiesis and hepcidin levels via renal EPO induction in mice.
    Nakai T; Iwamura Y; Kato K; Hirano I; Matsumoto Y; Tomioka Y; Yamamoto M; Suzuki N
    Blood Adv; 2023 Aug; 7(15):3793-3805. PubMed ID: 37146271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulating iron-erythropoiesis regulation: transferrin receptor 2 as potential target for treating anemia in CKD.
    Koury MJ; Haase VH
    Kidney Int; 2023 Jul; 104(1):25-28. PubMed ID: 37349056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Jian-Pi-Yi-Shen formula ameliorates renal fibrosis-induced anemia in rats with chronic kidney disease.
    Huang H; Huang S; Li C; Zhang C; Wang R; Wei L; Wu J; Mo P; Li Z; Li S; Chen J
    J Ethnopharmacol; 2024 Dec; 335():118607. PubMed ID: 39069029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiology and pathophysiology of renal erythropoietin-producing cells.
    Shih HM; Wu CJ; Lin SL
    J Formos Med Assoc; 2018 Nov; 117(11):955-963. PubMed ID: 29655605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kynurenine, by activating aryl hydrocarbon receptor, decreases erythropoietin and increases hepcidin production in HepG2 cells: A new mechanism for anemia of inflammation.
    Eleftheriadis T; Pissas G; Antoniadi G; Liakopoulos V; Stefanidis I
    Exp Hematol; 2016 Jan; 44(1):60-7.e1. PubMed ID: 26325330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-inducible factor stabilizers for treating anemia of chronic kidney disease.
    Hasegawa S; Tanaka T; Nangaku M
    Curr Opin Nephrol Hypertens; 2018 Sep; 27(5):331-338. PubMed ID: 30067604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of erythropoietin deficiency in mice with systemically administered siRNA.
    Querbes W; Bogorad RL; Moslehi J; Wong J; Chan AY; Bulgakova E; Kuchimanchi S; Akinc A; Fitzgerald K; Koteliansky V; Kaelin WG
    Blood; 2012 Aug; 120(9):1916-22. PubMed ID: 22611156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mimicking hypoxia to treat anemia: HIF-stabilizer BAY 85-3934 (Molidustat) stimulates erythropoietin production without hypertensive effects.
    Flamme I; Oehme F; Ellinghaus P; Jeske M; Keldenich J; Thuss U
    PLoS One; 2014; 9(11):e111838. PubMed ID: 25392999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-inducible factor prolyl hydroxylase inhibitor in the treatment of anemia in chronic kidney disease.
    Kurata Y; Tanaka T; Nangaku M
    Curr Opin Nephrol Hypertens; 2020 Jul; 29(4):414-422. PubMed ID: 32452915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrogen sulfide upregulates hypoxia inducible factors and erythropoietin production in chronic kidney disease induced by 5/6 nephrectomized rats.
    Hajiaqaei M; Ranjbaran M; Kadkhodaee M; Shafie A; Abdi A; Lorian K; Kianian F; Seifi B
    Mol Biol Rep; 2024 Aug; 51(1):916. PubMed ID: 39158746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.